Flagship Pioneering’s Post

Flagship Pioneering reposted this

View organization page for Foghorn Therapeutics Inc., graphic

16,385 followers

We're pleased to share new research in collaboration with NEO Proteomics that was published in ACS Publications. In addition to mapping the binding site of a crotonylated histone 3 peptide (H3K14Cr) to BAF45D, this study went on to demonstrate the direct binding of H3K14Cr to BRM. Overall, this study illustrates the power of mass spectrometry-based protein footprinting to map binding interfaces in large, multisubunit complexes with new insights into the BRG-/BRM-associated factor (BAF) chromatin remodeling complex. Read here: https://bit.ly/3xHHer0

  • No alternative text description for this image
Stephen Carriere

Strategic Finance Executive & Business Partner | Financial & Business Reporting Systems | Transformation | Continuous Improvement Mindset | Mergers, Acquisitions, Divestitures & Restructurings | Empowering Finance Teams

3w

Check out the Bruker mass spectrometry products at Bruker.com

Like
Reply

To view or add a comment, sign in

Explore topics